Premium
The value of antenatal cardiotocography in the management of high‐risk pregnancy: a randomized controlled trial
Author(s) -
BROWN VALERIE A.,
SAWERS R. S.,
PARSONS R. J.,
DUNCAN SHEILA L. B.,
COOKE I. D.
Publication year - 1982
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1982.tb05097.x
Subject(s) - cardiotocography , medicine , randomized controlled trial , obstetrics , pregnancy , apgar score , high risk pregnancy , fetus , surgery , genetics , biology
Summary. The value of routine regular antenatal cardiotocography (CTG) in the management of high‐risk pregnancy was assessed in a prospective randomized controlled study of 353 patients. All patients had a weekly CTG trace during the last 6 weeks of pregnancy and according to random allocation the tracings were concealed from, or available to, the clinicians. Other methods of assessing fetal welfare were available to both groups. There was no significant difference between the concealed and revealed groups in the timing and mode of delivery, birthweights, Apgar score and neonatal morbidity. No apparent effect from the routine use of antenatal CTG in high‐risk pregnancy was shown.